Sun Biomedical announced Executive changes. Mr. Howard Digby and Dr. Anton Uvarov have resigned from their Non-Executive and Executive Director positions respectively. The company also announced appointment of Mr. David Franklyn as a Non-Executive Director.

Mr. Franklyn will retire immediately prior to Sun Biomedical's 2016 Annual General Meeting and be entitled to stand for re-election at that meeting. The Board of Sun Biomedical also announced that it is has received resignation of company secretary, Mr. Peter Webse effective at close of business on November 24, 2015. Mr. Ian Hobson will replace Mr. Webse as Company Secretary with immediate effect, and will also be the CFO for the company.

Hobson is currently Company Secretary and CFO of Dimerix Bioscience Limited.